Concord Medical Services Holdings Limited
Symbol: CCM
NYSE
0.52
USDTrhová cena dnes
-0.9214
Pomer P/E
0.0139
Pomer PEG
14.64M
MRK Cap
- 0.00%
Výnos DIV
Concord Medical Services Holdings Limited (CCM) Finančné výkazy
Súvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 58.1 | 158.3 | 157.4 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 0 | 73.5 | 512.8 | 383 | ||||||||||||||||
balance-sheet.row.inventory | 0 | 40.3 | 84.8 | 38.1 | ||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 412.9 | 24.3 | 6 | ||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 617.2 | 759.8 | 584.5 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 3734 | 3446.6 | 3347.7 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 575.4 | 575.4 | 581.9 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 721.1 | 762.1 | 1074.7 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1296.6 | 1337.5 | 1656.6 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 394.7 | 437.9 | 390.6 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 5.1 | 0 | 237 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 6.3 | 23.2 | 13.6 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 5436.7 | 5245.1 | 5645.5 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 0 | 6053.9 | 6004.9 | 6230 | ||||||||||||||||
balance-sheet.row.account-payables | 0 | 129.2 | 146.7 | 102.5 | ||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 1088.7 | 548.5 | 319.8 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 17.1 | 28.8 | 21 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 2207 | 2691.4 | 2412.8 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 44.5 | 0 | 81.2 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 674.1 | 325.2 | 301.1 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 2355.6 | 2868 | 2681.7 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 239.5 | 235.9 | 234.7 | ||||||||||||||||
balance-sheet.row.total-liab | 0 | 4307 | 3989.3 | 3486.2 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -4064.6 | -3766.9 | -3277.3 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -65.4 | -27.8 | -29.5 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2008 | 1930.6 | 1936.5 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | -2121.9 | -1864 | -1370.1 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 6053.9 | 6004.9 | 6230 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 3868.9 | 3879.6 | 4113.8 | ||||||||||||||||
balance-sheet.row.total-equity | 0 | 1747 | 2015.7 | 2743.7 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||
Total Investments | 0 | 394.7 | 437.9 | 390.6 | ||||||||||||||||
balance-sheet.row.total-debt | 0 | 3295.7 | 3239.9 | 2732.7 | ||||||||||||||||
balance-sheet.row.net-debt | 0 | 3237.6 | 3081.6 | 2575.3 |
Výkaz peňažných tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -769 | -522.7 | -404 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 132.8 | 104.1 | 80.3 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -71.8 | 11.3 | -13.3 | |||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -5.9 | 14.7 | 20.6 | |||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 105 | -46.6 | -32.6 | |||||||||||||||
cash-flows.row.account-receivables | 0 | 0.6 | -64.5 | -6.2 | |||||||||||||||
cash-flows.row.inventory | 0 | -46.8 | -4.4 | -14.4 | |||||||||||||||
cash-flows.row.account-payables | 0 | 113.7 | 262.8 | 11.1 | |||||||||||||||
cash-flows.row.other-working-capital | 0 | 37.4 | -240.6 | -23.1 | |||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 392.2 | 79.9 | 119.3 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -384.8 | -780.3 | -512.9 | |||||||||||||||
cash-flows.row.acquisitions-net | 0 | -2.3 | -66 | 62.4 | |||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 209.1 | -108.5 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 11.9 | 20 | -7.9 | |||||||||||||||
cash-flows.row.other-investing-activites | 0 | 256.4 | 51.2 | 33 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -118.8 | -566 | -533.9 | |||||||||||||||
cash-flows.row.debt-repayment | 0 | -394.6 | -230.8 | -1271 | |||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.other-financing-activites | 0 | 777.7 | 873.2 | 2409.3 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 383.1 | 642.4 | 1138.3 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -47.2 | -4.6 | -2.6 | |||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 0.4 | -287.5 | 372.1 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 159.3 | 158.9 | 446.4 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 158.9 | 446.4 | 74.3 | |||||||||||||||
cash-flows.row.operating-cash-flow | 0 | -216.7 | -359.3 | -229.8 | |||||||||||||||
cash-flows.row.capital-expenditure | 0 | -384.8 | -780.3 | -512.9 | |||||||||||||||
cash-flows.row.free-cash-flow | 0 | -601.5 | -1139.6 | -742.7 |
Riadok výkazu ziskov a strát
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 537.4 | 472.1 | 485.6 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 614 | 624.5 | 542.5 | ||||||||||||||||
income-statement-row.row.gross-profit | 0 | -76.6 | -152.4 | -56.9 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 0 | -10.8 | -216.6 | -1.2 | ||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 386.4 | 372.6 | 401.4 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1000.4 | 997.1 | 944 | ||||||||||||||||
income-statement-row.row.interest-income | 0 | 10.8 | 10 | 5.9 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | 165.7 | 120.4 | 73.8 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | 62.2 | -314.8 | -70.9 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -10.8 | -216.6 | -1.2 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | 62.2 | -314.8 | -70.9 | ||||||||||||||||
income-statement-row.row.interest-expense | 0 | 165.7 | 120.4 | 73.8 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 128.5 | -56.1 | 126.9 | ||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | 0 | -463 | -525 | -458.3 | ||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -555.6 | -839.9 | -529.2 | ||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -24.6 | -70.9 | -6.6 | ||||||||||||||||
income-statement-row.row.net-income | 0 | -297.7 | -769 | -522.7 |
Často kladené otázky
Čo je Concord Medical Services Holdings Limited (CCM) celkové aktíva?
Concord Medical Services Holdings Limited (CCM) celkové aktíva sú 6053943000.000.
Aký je ročný obrat podniku?
Ročné príjmy sú N/A.
Aké je ziskové rozpätie podniku?
Zisková marža firmy je -0.142.
Aký je voľný peňažný tok podniku?
Voľný peňažný tok je -26.194.
Aká je čistá zisková marža podniku?
Čistá zisková marža je -0.553.
Aké sú celkové výnosy podniku?
Celkové príjmy sú -0.861.
Aká je Concord Medical Services Holdings Limited (CCM) čistý zisk (čistý príjem)?
Čistý zisk (čistý príjem) je -297658000.000.
Aký je celkový dlh firmy?
Celkový dlh je 3295701000.000.
Aké je číslo prevádzkových nákladov?
Prevádzkové výdavky sú 386377000.000.
Aký je údaj o hotovosti spoločnosti?
Peňažné prostriedky podniku sú 0.000.